Bioinformatics analysis and identification of genes and molecular pathways in steroid-induced osteonecrosis of the femoral head.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
20 May 2021
Historique:
received: 29 03 2021
accepted: 06 05 2021
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 30 10 2021
Statut: epublish

Résumé

Steroid-induced osteonecrosis of the femoral head (ONFH) is a common hip joint disease and is difficult to be diagnosed early. At present, the pathogenesis of steroid-induced ONFH remains unclear, and recognized and effective diagnostic biomarkers are deficient. The present study aimed to identify potentially important genes and signaling pathways involved in steroid-induced ONFH and investigate their molecular mechanisms. Microarray data sets GSE123568 (peripheral blood) and GSE74089 (cartilage) were obtained from the Gene Expression Omnibus database, including 34 ONFH samples and 14 control samples. Morpheus software and Venn diagram were used to identify DEGs and co-expressed DEGs, respectively. Besides, we conducted Kyoto Encyclopedia of Genome (KEGG) and gene ontology (GO) pathway enrichment analysis. We construct a protein-protein interaction (PPI) network through GEO2R and used cytoHubba to divide the PPI network into multiple sub-networks. Additionally, quantitative real-time polymerase chain reaction (qRT-PCR) was performed to verify the bioinformatics analysis results. A total of 118 intersecting DEGs were obtained between the peripheral blood and cartilage samples, including 40 upregulated genes and 78 downregulated genes. Then, GO and KEGG pathway enrichment analysis revealed that upregulated DEGs focused on the signaling pathways related to staphylococcus aureus infection, leishmaniasis, antigen processing, and presentation, as well as asthma and graft-versus-host disease. Downregulated genes were concentrated in the FoxO signaling pathway, AMPK signaling pathway, signaling pathway regulating stem cell pluripotency, and mTOR signaling pathway. Some hub genes with high interactions such as CXCR1, FPR1, MAPK1, FOXO3, FPR2, CXCR2, and TYROBP were identified in the PPI network. The results of qRT-PCR demonstrated that CXCR1, FPR1, and TYROBP were upregulated while MAPK1 was downregulated in peripheral blood of steroid-induced ONFH patients. This was consistent with the bioinformatics analysis. The present study would provide novel insight into the genes and associated pathways involved in steroid-induced ONFH. CXCR1, FPR1, TYROBP, and MAPK1 may be used as potential drug targets and biomarkers for the diagnosis and prognosis of steroid-induced ONFH.

Sections du résumé

BACKGROUND BACKGROUND
Steroid-induced osteonecrosis of the femoral head (ONFH) is a common hip joint disease and is difficult to be diagnosed early. At present, the pathogenesis of steroid-induced ONFH remains unclear, and recognized and effective diagnostic biomarkers are deficient. The present study aimed to identify potentially important genes and signaling pathways involved in steroid-induced ONFH and investigate their molecular mechanisms.
METHODS METHODS
Microarray data sets GSE123568 (peripheral blood) and GSE74089 (cartilage) were obtained from the Gene Expression Omnibus database, including 34 ONFH samples and 14 control samples. Morpheus software and Venn diagram were used to identify DEGs and co-expressed DEGs, respectively. Besides, we conducted Kyoto Encyclopedia of Genome (KEGG) and gene ontology (GO) pathway enrichment analysis. We construct a protein-protein interaction (PPI) network through GEO2R and used cytoHubba to divide the PPI network into multiple sub-networks. Additionally, quantitative real-time polymerase chain reaction (qRT-PCR) was performed to verify the bioinformatics analysis results.
RESULTS RESULTS
A total of 118 intersecting DEGs were obtained between the peripheral blood and cartilage samples, including 40 upregulated genes and 78 downregulated genes. Then, GO and KEGG pathway enrichment analysis revealed that upregulated DEGs focused on the signaling pathways related to staphylococcus aureus infection, leishmaniasis, antigen processing, and presentation, as well as asthma and graft-versus-host disease. Downregulated genes were concentrated in the FoxO signaling pathway, AMPK signaling pathway, signaling pathway regulating stem cell pluripotency, and mTOR signaling pathway. Some hub genes with high interactions such as CXCR1, FPR1, MAPK1, FOXO3, FPR2, CXCR2, and TYROBP were identified in the PPI network. The results of qRT-PCR demonstrated that CXCR1, FPR1, and TYROBP were upregulated while MAPK1 was downregulated in peripheral blood of steroid-induced ONFH patients. This was consistent with the bioinformatics analysis.
CONCLUSIONS CONCLUSIONS
The present study would provide novel insight into the genes and associated pathways involved in steroid-induced ONFH. CXCR1, FPR1, TYROBP, and MAPK1 may be used as potential drug targets and biomarkers for the diagnosis and prognosis of steroid-induced ONFH.

Identifiants

pubmed: 34016144
doi: 10.1186/s13018-021-02464-9
pii: 10.1186/s13018-021-02464-9
pmc: PMC8136174
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
CXCR2 protein, human 0
FOXO3 protein, human 0
FPR1 protein, human 0
Forkhead Box Protein O3 0
Glucocorticoids 0
Membrane Proteins 0
Receptors, Formyl Peptide 0
Receptors, Interleukin-8A 0
Receptors, Interleukin-8B 0
TYROBP protein, human 0
MAPK1 protein, human EC 2.7.11.24
Mitogen-Activated Protein Kinase 1 EC 2.7.11.24

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

327

Subventions

Organisme : Natural Science Foundation of China
ID : 81873327
Organisme : Natural Science Foundation of China
ID : 81904226

Références

World J Orthop. 2015 Sep 18;6(8):590-601
pubmed: 26396935
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
J Biol Chem. 2011 May 13;286(19):17133-43
pubmed: 21372136
Stem Cells. 2014 Aug;32(8):2256-66
pubmed: 24659476
Sci Rep. 2016 Mar 02;6:22599
pubmed: 26932538
Mol Cell Biol. 2009 Nov;29(21):5843-57
pubmed: 19737917
Sci Rep. 2016 Dec 02;6:38491
pubmed: 27910957
Biochem J. 2012 Jul 1;445(1):11-27
pubmed: 22702974
Clin Orthop Relat Res. 2014 Feb;472(2):617-23
pubmed: 23943529
Arthritis. 2012;2012:601763
pubmed: 23243507
J Bone Joint Surg Am. 2015 Oct 7;97(19):1604-27
pubmed: 26446969
Biol Blood Marrow Transplant. 2008 Oct;14(10):1081-1087
pubmed: 18804037
Orthop Clin North Am. 2019 Apr;50(2):139-149
pubmed: 30850073
BMC Bioinformatics. 2017 Sep 2;18(1):389
pubmed: 28865426
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
Cell Stem Cell. 2009 Apr 3;4(4):324-35
pubmed: 19341622
Biochem Biophys Res Commun. 2017 Jun 03;487(3):660-665
pubmed: 28438603
Cancer Cell. 2013 Dec 9;24(6):766-76
pubmed: 24291004
Int Orthop. 2016 Jul;40(7):1347-51
pubmed: 26728612
Stem Cells. 2016 Aug;34(8):2157-68
pubmed: 27145264
Br J Haematol. 1997 Jun;97(4):865-70
pubmed: 9217190
Bone. 2017 Aug;101:104-112
pubmed: 28476574
Clin Sci (Lond). 2012 Jun;122(12):555-73
pubmed: 22390198
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Int J Med Sci. 2018 Aug 10;15(12):1355
pubmed: 30275763
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70
pubmed: 25969447
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Biomed Pharmacother. 2015 Oct;75:191-5
pubmed: 26298803
Mech Dev. 2017 Feb;143:42-52
pubmed: 28132765
J Exp Med. 2015 Jan 12;212(1):73-91
pubmed: 25534817
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Cell Transplant. 2015;24(6):1067-83
pubmed: 24759682
J Bone Joint Surg Am. 2005 Jun;87(6):1272-7
pubmed: 15930536
Methods Mol Biol. 2016;1375:207-21
pubmed: 25971912
Oncotarget. 2016 Oct 18;7(42):68434-68441
pubmed: 27637086
Oncotarget. 2017 Feb 7;8(6):10543-10552
pubmed: 28060740
Chin Med J (Engl). 2018 Nov 5;131(21):2589-2598
pubmed: 30381593

Auteurs

Tianye Lin (T)

The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
The Lab of Orthopaedics of Chinese Medicine of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Department of Joint Orthopaedic, the Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Institute of Orthopedics, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

Weijian Chen (W)

Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Guangzhou Orthopedic Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510045, Guangdong, China.
The Lab of Orthopaedics of Chinese Medicine of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

Peng Yang (P)

The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
The Lab of Orthopaedics of Chinese Medicine of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Department of Joint Orthopaedic, the Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Institute of Orthopedics, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

Ziqi Li (Z)

Department of Joint Orthopaedic, the Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Institute of Orthopedics, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

Qiushi Wei (Q)

Department of Joint Orthopaedic, the Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Institute of Orthopedics, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

Du Liang (D)

Guangzhou Orthopedic Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510045, Guangdong, China.

Haibin Wang (H)

Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
The Lab of Orthopaedics of Chinese Medicine of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

Wei He (W)

Department of Joint Orthopaedic, the Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Institute of Orthopedics, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

Qingwen Zhang (Q)

Department of Joint Orthopaedic, the Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China. zh__qwen@163.com.
Institute of Orthopedics, Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China. zh__qwen@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH